Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rewarding Feedback in Motor Learning and Rehabilitation (KFSP-REWARD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02189564
Recruitment Status : Completed
First Posted : July 14, 2014
Last Update Posted : May 2, 2016
Sponsor:
Collaborator:
University of Zurich
Information provided by (Responsible Party):
Kai Lutz, PhD, Cereneo AG

Brief Summary:

The effect of rewarding vs. non-rewarding feedback on acquisition of a motor skill is investigated in a single blinded parallel group design. Reward consists of performance dependent monetary reward, or of knowledge of performance in selected (above average) trials.

The investigators hypothesize improved motor skill learning and higher involvement of the dopaminsrgic system under rewarding vs. non-rewarding conditions.


Condition or disease Intervention/treatment Phase
Motor Performance Motor Learning Behavioral: Feedback about good performance Behavioral: Feedback about good performance + money Behavioral: Feedback about average performance Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Die Auswirkung Von Dopaminergen Belohnungsreizen Auf Das Lernen Einer Motorischen Fertikgeit Bei Gesunden Probanden "Effects of Dopaminergic Reward on Motor Skill Learning in Healthy Subjects"
Study Start Date : January 2014
Actual Primary Completion Date : July 2014
Actual Study Completion Date : April 2016

Arm Intervention/treatment
Active Comparator: Intrinsic reward
Feedback about good performance
Behavioral: Feedback about good performance
Experimental: Intrinsic and extrinsic reward
Feedback about good performance + money
Behavioral: Feedback about good performance + money
Experimental: Intrinsic reward (average performance)
Feedback about random selection of trials
Behavioral: Feedback about average performance



Primary Outcome Measures :
  1. Motor skill learning using an arc pointing task [ Time Frame: about 10 minutes pre-training, about 10 min post training, about 24h post training ]
    temporal and spacial precision in an arc pointing task will be assessed using 5 different movement speeds during the above mentioned time periods before and after a specific motor learning programm. Learning will be assessed as change from pre-training to post training



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • neurologically healthy
  • right handed

Exclusion Criteria:

  • Contraindications against magnetic resonance imaging
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02189564


Locations
Layout table for location information
Switzerland
Cereneo, Center For Rehabilitation and Neurology
Vitznau, Lucerne, Switzerland, 6354
Sponsors and Collaborators
Kai Lutz, PhD
University of Zurich
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Kai Lutz, PhD, Scientific Director, Cereneo AG
ClinicalTrials.gov Identifier: NCT02189564    
Other Study ID Numbers: KFSP-SUB1-LU13054
First Posted: July 14, 2014    Key Record Dates
Last Update Posted: May 2, 2016
Last Verified: April 2016